Mobile health monitoring in the management of long term conditions has potential benefits for patient care, especially when coupled with active adjustment of medication dosage. We report studies of patient-led self-titration of oral glucose lowering medication (OGLM) and insulin in type 2 diabetes, and dose adjustments (including dose increases) in oral chemotherapy for metastatic colorectal or breast cancer. Monitoring compliance was high in each case, and the feasibility of patients self-titrating OGLM or insulin following an agreed treatment plan was demonstrated. Chemotherapy dose increases supported by detailed toxicity profiles collected by phone have also been demonstrated.

Original publication

DOI

10.1109/IEMBS.2011.6090449

Type

Journal article

Journal

Conf Proc IEEE Eng Med Biol Soc

Publication Date

2011

Volume

2011

Pages

1540 - 1543

Keywords

Administration, Oral, Antimetabolites, Antineoplastic, Blood Glucose Self-Monitoring, Capecitabine, Deoxycytidine, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Drug Therapy, Computer-Assisted, Female, Fluorouracil, Humans, Hypoglycemic Agents, Insulin, Neoplasms, Telemedicine, Treatment Outcome